Jpmorgan Chase & CO Grifols Sa Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Grifols Sa stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,002,511 shares of GRFS stock, worth $15.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,002,511

Previous 820,552 144.04%

Holding current value

$15.7 Million

Previous $5.17 Million 244.01%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	BUY	$6.28 - $9.38 $7.42 Million - $11.1 Million	1,181,959 Added 144.04%	2,002,511 $17.8 Million
Q3 2024 Nov 08, 2024	BUY	$6.28 - $9.38 $7.42 Million - $11.1 Million	1,181,959 Added 144.04%	2,002,511 $17.8 Million
Q2 2024 Dec 26, 2024	SELL	$6.27 - $7.7 $7.41 Million - $9.1 Million	-1,181,959 Reduced 59.02%	820,552 $5.17 Million
Q2 2024 Aug 12, 2024	SELL	$6.27 - $7.7 $1.45 Million - $1.78 Million	-231,723 Reduced 22.02%	820,552 $5.17 Million
Q1 2024 Dec 26, 2024	SELL	$5.47 - $11.38 $5.2 Million - $10.8 Million	-950,236 Reduced 47.45%	1,052,275 $7.03 Million
Q1 2024 May 10, 2024	SELL	$5.47 - $11.38 $4.6 Million - $9.58 Million	-841,504 Reduced 44.44%	1,052,275 $7.03 Million
Q4 2023 Dec 26, 2024	SELL	$7.71 - $11.56 $838,323 - $1.26 Million	-108,732 Reduced 5.43%	1,893,779 $21.9 Million
Q4 2023 Feb 12, 2024	BUY	$7.71 - $11.56 $4.05 Million - $6.07 Million	525,162 Added 38.37%	1,893,779 $21.9 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $2.93 Million - $3.59 Million	329,372 Added 31.69%	1,368,617 $12.5 Million
Q2 2023 Aug 11, 2023	SELL	$7.14 - $9.29 $6.31 Million - $8.21 Million	-884,256 Reduced 45.97%	1,039,245 $9.52 Million
Q1 2023 May 11, 2023	BUY	$6.65 - $10.69 $2.28 Million - $3.67 Million	342,912 Added 21.7%	1,923,501 $14.2 Million
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.53 $5.94 Million - $8.5 Million	-995,903 Reduced 38.65%	1,580,589 $13.4 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $3.14 Million - $7.54 Million	-527,393 Reduced 16.99%	2,576,492 $15.9 Million
Q2 2022 Aug 11, 2022	SELL	$10.6 - $13.28 $1.06 Million - $1.33 Million	-100,030 Reduced 3.12%	3,103,885 $36.9 Million
Q1 2022 May 11, 2022	SELL	$10.37 - $12.73 $780,031 - $957,550	-75,220 Reduced 2.29%	3,203,915 $37.4 Million
Q4 2021 Feb 10, 2022	SELL	$10.21 - $15.27 $3.39 Million - $5.07 Million	-332,150 Reduced 9.2%	3,279,135 $36.8 Million
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $50.8 Million - $62.5 Million	3,611,285 New	3,611,285 $52.8 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Grifols Sa Transaction History